Loading financial data...

Protagenic Therapeutics, Inc.new (PTIX) Financial Statements | Global Financial Data

Protagenic Therapeutics, Inc.new

PTIXSEC EDGAR

Pharmaceutical Preparations(DE)CIK: 1022899

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Revenues	$0.00	$0.00	$0.00	$0.00	—
Research and Development Expense	$3.1M	$1.6M	$1.1M	$699.8K	$807.9K
Operating Expenses	$4.5M	$3.6M	$4.1M	$2.6M	$2.1M
Operating Income (Loss)	-$4.5M	-$3.6M	-$4.1M	-$2.6M	-$2.1M
Interest Expense	—	$137.5K	$496.9K	$246.2K	—
Nonoperating Income (Expense)	-$473.5K	$2.3K	-$382.5K	$2.9K	$335.2K
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	-$5.0M	-$3.6M	-$4.5M	-$2.5M

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Assets	$4.3M	$8.0M	$11.1M	$879.2K	$842.3K
Assets, Current	$4.2M	$8.0M	$11.1M	$879.2K	$842.0K
Cash and Cash Equivalents, at Carrying Value	—	—	—	—	$798.6K
Liabilities	$655.3K	$1.1M	$1.1M	$2.0M	$1.5M
Liabilities, Current	$655.3K	$1.1M	$799.5K	$655.2K	$1.2M
Accounts Payable, Current	—	—	—	—	—
Stockholders' Equity Attributable to Parent	$6.9M	$9.9M	-$1.1M	-$634.4K	-$210.9K

Concept	FY2024	FY2023	FY2022	FY2021	FY2020
Net Cash Provided by (Used in) Operating Activities	-$3.7M	-$2.0M	-$2.8M	-$1.3M	-$488.0K
Net Cash Provided by (Used in) Investing Activities	$4.8M	$1.6M	-$9.9M	-$9.9M	$250.0K
Net Cash Provided by (Used in) Financing Activities	$2.0M	—	$12.6M	$1.2M	$670.0K
Payments to Acquire Property, Plant, and Equipment	—	—	—	—	—

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)